Why Choose City of Hope
Treating cancer begins with understanding that cancer is different than other health conditions. It is highly complex, with hundreds of different cancer sub-types. Optimal care and outcomes require treatment by experts who specialize in your specific type of cancer, understand the genetics of your disease, and deliver a patient-centric approach throughout the entire cancer journey. Today we are witnessing a decrease in cancer mortality rates in the U.S., which validates the clinical innovation and integrated care that City of Hope delivers.
A National Leader in Cancer Care
Founded in 1913, City of Hope is a national leader in cancer care. We provide each patient with an individualized, comprehensive care experience and deliver the highest quality treatment and expertise.
We are one of only 52 National Cancer Institute (NCI)-designated comprehensive cancer centers in the U.S. The NCI designation recognizes excellence in treatment, research and expertise to address the many faces of the disease, whether in early or late stage, and for common or rare types of cancer.
City of Hope is also proud to be a founding member of the National Comprehensive Cancer Network (NCCN), reflecting our national leadership in advancing research and treatment. NCCN member institutions are recognized for their world-renowned experts and for treating complex, rare and aggressive forms of cancer.
Most importantly, we firmly believe in providing value across the entire patient journey. At City of Hope, this is measured by the experiences and outcomes that our treatments and dedicated team provide. Our goal is to care for the whole person, so that life during treatment and after cancer can be rich and rewarding.
Our Unique Approach to the Delivery of Care for You and Your Loved Ones
Compassion and discovery are at the heart of our approach. Thanks to the expertise and dedication of our physicians and staff, we can treat rare and complex cancers that others cannot. Our scientists, clinicians and specialists work under one roof, meaning that each patient receives coordinated care from a team of physicians.
City of Hope patients benefit from our extraordinary capabilities and leading-edge technology advances such as the application of robotics to remove disease and the use of innovative methods to deliver chemotherapy to treat tumors that would otherwise be unreachable; the use of genetically re-engineered white cells to target and attack a patient’s cancer cells; and the use of advanced imaging techniques to more precisely deliver radiation therapy.
Our support also extends to our community through our network of clinical locations. We work with our patients and their families at each step of the journey, providing interdisciplinary supportive services, including psychology, patient education, support groups such as Couples Coping With Cancer, social work, physical and occupational therapy, and nutritional and financial counseling.
Underpinning this approach is our excellence in turning tomorrow’s treatments into today’s tailored patient plans and therapies. We are committed to delivering the most leading-edge treatment options to our patients and discovering new ways to combat a wide variety of cancers.
Delivering Optimal Outcomes for Our Patients
NCI-designated comprehensive cancer centers like City of Hope are the reason that cancer mortality rates have fallen over the past four decades. City of Hope consistently demonstrates higher survival rates and better outcomes, compared to other health care providers.
City of Hope and its nursing team have achieved Magnet® recognition from the American Nurses Credentialing Center. Given only after a rigorous assessment of a hospital or medical center, Magnet recognition is one of the highest honors in nursing and a global recognition of the cancer center’s outstanding commitment to excellence in health care delivery and improvement of patient outcomes.
Our patients recognize our commitment and our ability to provide life-changing outcomes.
Why Our Research and Innovation Matters
City of Hope is a leader in research and innovation, which continually enhances our ability to provide novel and differentiated approaches to cancer care. With our scientists, clinical staff and manufacturing specialists working side-by-side, advances in treatment can travel from laboratory to patient with lifesaving speed.
- Clinical trial participation is a critical aspect of care for many patients living with cancer. Our patients can access more than 500 clinical trials investigating potentially groundbreaking treatments. Today, City of Hope enrolled more than 6,000 patients in clinical trials this year, including in over 100 clinical trials in breast cancer alone. These trials provide unique treatment options to City of Hope patients and pave the way for important breakthrough therapies.
- City of Hope is a pioneer in bone marrow and stem cell transplants. As one of the largest and most successful programs of its kind in the U.S., our program attracts patients across the nation and world.
- Numerous breakthrough cancer drugs, including Herceptin, Erbitux, Rituxan and Avastin, are based on technology pioneered by City of Hope.
- City of Hope is at the leading edge of an immunotherapy called chimeric antigen receptor therapy — also known as CAR T cell therapy — with one of the most comprehensive programs in the world, and more than 45 clinical trials either in process or completed, targeting various hematologic and solid tumors, including brain tumors.